您的贡献使我们的非营利组织得以继续 providing
Ascendis Pharma is applying its innovative platform technology to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients’ lives. Guided by its core values of patients, science and passion, the company utilizes its TransCon™ technologies to create new and potentially best-in-class therapies. Ascendis Pharma currently has a pipeline of three independent endocrinology rare disease product candidates in clinical development and is advancing oncology as its second therapeutic area of focus. The company continues to expand into additional therapeutic areas to address unmet patient needs.
Ascendis is headquartered in Copenhagen, Denmark, with additional offices in Heidelberg and Berlin, Germany, and in Palo Alto and Redwood City, California.
For more information, please visit www.ascendispharma.com.
Or, email Ascendis Pharma, Inc. at medicalinformation@ascendispharma.com
Novo Nordisk is a global healthcare company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for 95 years. This heritage has given us experience and capabilities that also enable us to help people defeat other serious diseases including obesity, hemophilia and growth disorders.
We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term and do business in a financially, socially and environmentally responsible way. With U.S. headquarters in New Jersey and production and research facilities in six states, Novo Nordisk employs nearly 6,000 people throughout the country.
For more information, visit novonordisk.us, Facebook, Instagram and Twitter.
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases.
The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com.
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across our Allergan Aesthetics portfolio. For additional information, please visit www.abbvie.com.
Endo is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them. Learn more at www.endo.com.
虚拟展厅 www.Pfizer.com.
Ascendis Pharma 正在应用其创新平台技术打造一家领先的、完全整合的生物制药公司，专注于为患者的生活带来有意义的改变。在其患者、科学和热情的核心价值观的指导下，该公司利用其 TransCon ™技术创造新的和可能是一流的疗法。 Ascendis Pharma 目前在临床开发中拥有三个独立的内分泌学罕见疾病候选产品管道，并将肿瘤学作为其第二个重点治疗领域。公司继续扩展到其他治疗领域，以满足未满足的患者需求。
Ascendis 总部位于丹麦哥本哈根，在德国海德堡和柏林以及加利福尼亚州帕洛阿尔托和雷德伍德城设有办事处。
For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.
